Two deaths and more than 100 hospitalisations have been linked to a growing health scare in Japan around dietary supplements meant to lower cholesterol, the government said.
Authorities are investigating after the over-the-counter tablets were recalled by Japanese drugmaker Kobayashi Pharmaceutical following kidney complaints from customers.
